364 related articles for article (PubMed ID: 21925122)
1. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
2. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
Dubé PE; Rowland KJ; Brubaker PL
Endocrinology; 2008 Jan; 149(1):291-301. PubMed ID: 17884945
[TBL] [Abstract][Full Text] [Related]
4. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
Fesler Z; Mitova E; Brubaker PL
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
[TBL] [Abstract][Full Text] [Related]
5. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.
Bahrami J; Yusta B; Drucker DJ
Gastroenterology; 2010 Jun; 138(7):2447-56. PubMed ID: 20226187
[TBL] [Abstract][Full Text] [Related]
6. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.
Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL
J Pediatr Surg; 2010 May; 45(5):987-95. PubMed ID: 20438940
[TBL] [Abstract][Full Text] [Related]
7. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
[TBL] [Abstract][Full Text] [Related]
8. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
McDonagh SC; Lee J; Izzo A; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
[TBL] [Abstract][Full Text] [Related]
9. IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine.
Austin K; Imam NA; Pintar JE; Brubaker PL
Endocrinology; 2015 Feb; 156(2):429-36. PubMed ID: 25514089
[TBL] [Abstract][Full Text] [Related]
10. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat.
Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL
FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
[TBL] [Abstract][Full Text] [Related]
12. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.
Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ
Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
14. The "cryptic" mechanism of action of glucagon-like peptide-2.
Rowland KJ; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G1-8. PubMed ID: 21527727
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.
Ivory CP; Wallace LE; McCafferty DM; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1202-10. PubMed ID: 18845573
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet.
Baldassano S; Amato A; Cappello F; Rappa F; Mulè F
J Endocrinol; 2013 Apr; 217(1):11-20. PubMed ID: 23308022
[TBL] [Abstract][Full Text] [Related]
17. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.
Dubé PE; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E460-5. PubMed ID: 17652153
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL
J Dairy Sci; 2011 Feb; 94(2):888-98. PubMed ID: 21257057
[TBL] [Abstract][Full Text] [Related]
19. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
